• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VCAN的高表达是胃癌预后不良的独立预测指标。

High expression of VCAN is an independent predictor of poor prognosis in gastric cancer.

作者信息

Li Wenfei, Han Fang, Fu Min, Wang Zhanqiu

机构信息

Department of Radiology, Affiliated Zhongshan Hospital of DaLian University, Dalian, Liaoning, China.

Department of Radiology, The First Hospital of Qinhuangdao, Qinhuangdao, Hebei, China.

出版信息

J Int Med Res. 2020 Jan;48(1):300060519891271. doi: 10.1177/0300060519891271.

DOI:10.1177/0300060519891271
PMID:31939331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7254169/
Abstract

OBJECTIVE

Versican (VCAN) has been reported as a potential biomarker in some cancers. However, its role in gastric cancer (GC) is poorly understood.

METHODS

Associations between clinical variables and VCAN were assessed. The diagnostic value of VCAN expression in GC patients was determined through receiver operating characteristic (ROC) curve analysis. Cox regression and the Kaplan–Meier method were used to explore clinicopathologic factors related to overall survival in GC patients. The Gene Expression Omnibus and the Human Protein Atlas were used for further validation. Gene set enrichment analysis (GSEA) was performed using The Cancer Genome Atlas dataset.

RESULTS

High expression of VCAN was associated with high stage and T classification in GC. The area under the ROC curve was 0.853. Patients with high VCAN expression had worse prognoses than those with low VCAN expression. Multivariate analysis showed that VCAN was an independent risk factor for overall survival in both cohorts. GSEA identified pathways involved in cancer, ECM-receptor interaction, Wnt signaling, T cell receptor signaling, and chemokine signaling as differentially enriched in GCs with high VCAN expression.

CONCLUSION

We demonstrated that VCAN is expressed at high levels in GC, and represents a potential independent molecular marker for diagnosis and prognosis of GC.

摘要

目的

据报道,多功能蛋白聚糖(VCAN)在某些癌症中是一种潜在的生物标志物。然而,其在胃癌(GC)中的作用尚不清楚。

方法

评估临床变量与VCAN之间的关联。通过受试者工作特征(ROC)曲线分析确定VCAN表达在GC患者中的诊断价值。采用Cox回归和Kaplan-Meier方法探讨与GC患者总生存相关的临床病理因素。利用基因表达综合数据库和人类蛋白质图谱进行进一步验证。使用癌症基因组图谱数据集进行基因集富集分析(GSEA)。

结果

GC中VCAN的高表达与高分期和T分级相关。ROC曲线下面积为0.853。VCAN高表达的患者预后比低表达的患者差。多变量分析表明,在两个队列中,VCAN都是总生存的独立危险因素。GSEA确定,在VCAN高表达的GC中,参与癌症、细胞外基质-受体相互作用、Wnt信号传导、T细胞受体信号传导和趋化因子信号传导的通路存在差异富集。

结论

我们证明,VCAN在GC中高表达,是GC诊断和预后的潜在独立分子标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c1/7254169/3a1fd54bf80c/10.1177_0300060519891271-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c1/7254169/338e9025030e/10.1177_0300060519891271-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c1/7254169/f3af529a68bd/10.1177_0300060519891271-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c1/7254169/85c4eefbe310/10.1177_0300060519891271-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c1/7254169/fd3ac20517f9/10.1177_0300060519891271-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c1/7254169/12c947ff6d51/10.1177_0300060519891271-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c1/7254169/3a1fd54bf80c/10.1177_0300060519891271-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c1/7254169/338e9025030e/10.1177_0300060519891271-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c1/7254169/f3af529a68bd/10.1177_0300060519891271-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c1/7254169/85c4eefbe310/10.1177_0300060519891271-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c1/7254169/fd3ac20517f9/10.1177_0300060519891271-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c1/7254169/12c947ff6d51/10.1177_0300060519891271-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c1/7254169/3a1fd54bf80c/10.1177_0300060519891271-fig6.jpg

相似文献

1
High expression of VCAN is an independent predictor of poor prognosis in gastric cancer.VCAN的高表达是胃癌预后不良的独立预测指标。
J Int Med Res. 2020 Jan;48(1):300060519891271. doi: 10.1177/0300060519891271.
2
H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.H19 可作为诊断生物标志物,H19 表达上调与胃癌患者预后不良有关。
Neoplasma. 2016;63(2):223-30. doi: 10.4149/207_150821N454.
3
Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer.用于胃癌诊断和预后的五lncRNA特征的鉴定
Tumour Biol. 2016 Oct;37(10):13265-13277. doi: 10.1007/s13277-016-5185-9. Epub 2016 Jul 26.
4
Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.血清血管生成素样蛋白2作为胃癌患者诊断、早期复发及预后的潜在生物标志物。
Carcinogenesis. 2015 Dec;36(12):1474-83. doi: 10.1093/carcin/bgv139. Epub 2015 Sep 28.
5
KCND2 upregulation might be an independent indicator of poor survival in gastric cancer.KCND2 的上调可能是胃癌患者生存不良的一个独立指标。
Future Oncol. 2018 Nov;14(27):2811-2820. doi: 10.2217/fon-2018-0418. Epub 2018 Jul 27.
6
MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.miR-1236-3p 可作为胃癌的新型诊断和预后生物标志物。
Cancer Biomark. 2019;25(2):127-132. doi: 10.3233/CBM-171026.
7
Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.整合分析鉴定 SLC5A6 和 MFAP2 为胃癌患者的新型诊断和预后生物标志物。
Int J Oncol. 2020 Feb;56(2):460-469. doi: 10.3892/ijo.2019.4944. Epub 2019 Dec 16.
8
Decreased expression of Siglec-8 associates with poor prognosis in patients with gastric cancer after surgical resection.唾液酸结合免疫球蛋白样凝集素8(Siglec-8)表达降低与胃癌患者手术切除后的不良预后相关。
Tumour Biol. 2016 Aug;37(8):10883-91. doi: 10.1007/s13277-016-4859-7. Epub 2016 Feb 16.
9
Gene expression signature-based prognostic risk score in gastric cancer.基于基因表达谱的胃癌预后风险评分。
Clin Cancer Res. 2011 Apr 1;17(7):1850-7. doi: 10.1158/1078-0432.CCR-10-2180. Epub 2011 Mar 29.
10
Versican expression in tumor epithelial cells is correlated with a good prognosis in gastric cancer.肿瘤上皮细胞中多功能蛋白聚糖的表达与胃癌的良好预后相关。
Anticancer Res. 2014 Oct;34(10):5613-9.

引用本文的文献

1
Integrated single-cell and bulk transcriptomic analysis identifies a novel macrophage subtype associated with poor prognosis in breast cancer.整合单细胞和批量转录组分析鉴定出一种与乳腺癌预后不良相关的新型巨噬细胞亚型。
Cancer Cell Int. 2025 Mar 27;25(1):119. doi: 10.1186/s12935-025-03750-w.
2
Identification of potential shared gene signatures between gastric cancer and type 2 diabetes: a data-driven analysis.胃癌与2型糖尿病潜在共享基因特征的鉴定:一项数据驱动分析
Front Med (Lausanne). 2024 Jun 6;11:1382004. doi: 10.3389/fmed.2024.1382004. eCollection 2024.
3
Identification of survival-associated biomarkers based on three datasets by bioinformatics analysis in gastric cancer.

本文引用的文献

1
Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.整合生物信息学分析揭示胃癌中新型关键生物标志物和潜在候选小分子药物。
Pathol Res Pract. 2019 May;215(5):1038-1048. doi: 10.1016/j.prp.2019.02.012. Epub 2019 Feb 28.
2
Differentially expressed genes and are potential prognostic biomarkers for gastric cancer.差异表达基因是胃癌潜在的预后生物标志物。
Oncol Lett. 2019 Mar;17(3):3191-3202. doi: 10.3892/ol.2019.9952. Epub 2019 Jan 21.
3
ADAM17 promotes lymph node metastasis in gastric cancer via activation of the Notch and Wnt signaling pathways.
基于三个数据集通过生物信息学分析鉴定胃癌中与生存相关的生物标志物
World J Clin Cases. 2023 Jul 16;11(20):4763-4787. doi: 10.12998/wjcc.v11.i20.4763.
4
The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican.富含亮氨酸的小分子蛋白聚糖对癌症发病机制的影响概述,重点关注双糖链蛋白聚糖和光蛋白聚糖。
Cancers (Basel). 2023 Jul 9;15(14):3549. doi: 10.3390/cancers15143549.
5
Cancer-associated fibroblasts refine the classifications of gastric cancer with distinct prognosis and tumor microenvironment characteristics.癌症相关成纤维细胞通过不同的预后和肿瘤微环境特征细化了胃癌的分类。
Front Oncol. 2023 Jun 19;13:1158863. doi: 10.3389/fonc.2023.1158863. eCollection 2023.
6
Hub genes and pathways in gastric cancer: A comparison between studies that used normal tissues adjacent to the tumour and studies that used healthy tissues as calibrator.胃癌的枢纽基因和通路:使用肿瘤旁正常组织与使用健康组织作为校准物的研究之间的比较。
IET Syst Biol. 2023 Jun;17(3):131-141. doi: 10.1049/syb2.12065. Epub 2023 Apr 29.
7
MiRNA-30a-5p/VCAN Arrests Tumor Metastasis via Modulating the Adhesion of Lung Adenocarcinoma Cells.miRNA-30a-5p/VCAN 通过调控肺腺癌细胞黏附抑制肿瘤转移
Appl Biochem Biotechnol. 2023 Dec;195(12):7568-7582. doi: 10.1007/s12010-023-04444-7. Epub 2023 Apr 10.
8
Identification of Glucose Metabolism-Related Genes in the Progression from Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma.鉴定非酒精性脂肪性肝病向肝细胞癌进展过程中的葡萄糖代谢相关基因。
Genet Res (Camb). 2022 Nov 3;2022:8566342. doi: 10.1155/2022/8566342. eCollection 2022.
9
A prognostic signature model for unveiling tumor progression in lung adenocarcinoma.一种用于揭示肺腺癌肿瘤进展的预后特征模型。
Front Oncol. 2022 Nov 1;12:1019442. doi: 10.3389/fonc.2022.1019442. eCollection 2022.
10
Identification and verification of a glycolysis-related gene signature for gastric cancer.胃癌糖酵解相关基因特征的鉴定与验证
Ann Transl Med. 2022 Sep;10(18):1010. doi: 10.21037/atm-22-3980.
ADAM17 通过激活 Notch 和 Wnt 信号通路促进胃癌淋巴结转移。
Int J Mol Med. 2019 Feb;43(2):914-926. doi: 10.3892/ijmm.2018.4028. Epub 2018 Dec 17.
4
Development and validation of a nomogram for predicting survival in patients with gastrointestinal stromal tumours.开发和验证用于预测胃肠道间质瘤患者生存的列线图。
Eur J Surg Oncol. 2018 Oct;44(10):1657-1665. doi: 10.1016/j.ejso.2018.07.004. Epub 2018 Jul 20.
5
Identification of hub genes and potential molecular mechanisms in gastric cancer by integrated bioinformatics analysis.通过综合生物信息学分析鉴定胃癌中的枢纽基因和潜在分子机制
PeerJ. 2018 Jul 2;6:e5180. doi: 10.7717/peerj.5180. eCollection 2018.
6
Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway.长链非编码 RNA FEZF1-AS1 提示胃癌预后不良,并通过激活 Wnt 信号通路促进肿瘤发生。
Biomed Pharmacother. 2017 Dec;96:1103-1108. doi: 10.1016/j.biopha.2017.11.113. Epub 2017 Nov 24.
7
Prognostic value of visceral pleural invasion in non-small cell lung cancer: A propensity score matching study based on the SEER registry.非小细胞肺癌中脏层胸膜侵犯的预后价值:一项基于监测、流行病学和最终结果(SEER)数据库的倾向评分匹配研究
J Surg Oncol. 2017 Sep;116(3):398-406. doi: 10.1002/jso.24677. Epub 2017 May 22.
8
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
9
Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular Carcinoma.定量组织蛋白质组学分析揭示多功能蛋白聚糖是早期肝细胞癌的潜在生物标志物。
J Proteome Res. 2016 Jan 4;15(1):38-47. doi: 10.1021/acs.jproteome.5b00420. Epub 2015 Dec 18.
10
Prognostic significance of Versican expression in gastric adenocarcinoma.Versican表达在胃腺癌中的预后意义
Oncogenesis. 2015 Nov 30;4(11):e178. doi: 10.1038/oncsis.2015.36.